查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球製藥設備市場按設備類型（包裝機,混合/混合設備,灌裝機,破碎機,噴霧乾燥機,檢查設備,擠出機,片劑壓縮機）,最終產品（固體,液體）,地區預測到2028
市場調查報告書
商品編碼
1280000

全球製藥設備市場按設備類型（包裝機,混合/混合設備,灌裝機,破碎機,噴霧乾燥機,檢查設備,擠出機,片劑壓縮機）,最終產品（固體,液體）,地區預測到2028

Pharmaceutical Manufacturing Equipment Market by Equipment Type (Packaging, Mixing & Blending, Filling, Milling, Spray Drying, Inspection, Extrusion, Tablet Compression Presses), End-Product Type (Solid, Liquid) and Region - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 217 Pages | 訂單完成後即時交付

價格
簡介目錄

全球製藥設備市場規模預計將從2023年的145億美元增長到2028年的197億美元，2023年至2028年的複合年增長率為6.3%。

推動製藥設備市場增長的主要因素是世界各地為支持藥物創新和安全而建立的越來越多的監管框架,全球對仿製藥和醫療保健投資的需求增加以及對製藥製造靈活性的需求增加。 新興的製藥市場，尤其是中東和非洲，也是推動對技術先進的製藥設備需求的關鍵因素。

“預計在預測期內，包裝機械的複合年增長率最高，其次是噴霧乾燥機”

藥品包裝機在藥品製造過程中發揮著至關重要的作用，可確保藥品質量和安全並滿足法規要求。 具有序列化功能的包裝機正在推動需求，因為它們可以對單個藥物進行唯一識別和跟蹤，從而促進供應鏈透明度和產品認證。 製藥行業越來越關注可持續包裝。 需要支持環保包裝材料（例如可回收和可生物降解材料）的包裝機。 藥物噴霧乾燥器有助於確保活性藥物成分 (API) 在整個配方中均勻分佈，並且最終產品符合質量,純度和效力的要求規格。 高效準確的製劑噴霧乾燥對於生產可供患者安全使用的高質量藥物至關重要，從而推動需求。

“在預測期內，液體終端產品類型將以最高複合年增長率增長，其次是固體終端產品類型”

液體產品類型涵蓋不同類型的液體劑型，例如溶液劑,糖漿劑,混懸劑和乳劑。 對糖漿的需求正在增加。 這種藥物可以精確地加入到濃縮的糖溶液中，掩蓋不愉快的味道，因此特別受到老人和兒童的歡迎。 技術進步,廣泛的研發活動和臨床試驗創新使製造商能夠顯著提高液體製劑的保質期，使其成為許多難溶性固體製劑的可行替代品。 液體製劑比固體製劑具有更高的生物利用度，這意味著更多的活性成分被吸收到血液中。 這可以導致更有效的治療並降低副作用的風險，這是推動需求的另一個因素。

“預計亞太地區在預測期內的複合年增長率最高，其次是歐洲”

亞太地區的工業公司正在與政府合作解決藥物短缺問題。 此外，品牌藥價格飆升和主要藥物專利到期也推動了採用仿製藥的需求。 鼓勵該地區的政府和行業參與者通過安裝現代製藥生產設備來升級其製藥生產設施，以滿足日益增長的藥品需求，解決藥品短缺問題並提高生產能力。 印度擁有美國以外最多的符合美國 FDA 標準的製藥廠。 我們擁有超過 3,000 家製藥公司,超過 10,500 個生產設施和強大的高技能人才庫網絡。 此外，印度政府還推出了生產相關激勵 (PLI) 計劃等計劃，以提高國內製造能力，包括全球供應鏈中的高價值產品。

德國是 2021 年最大的藥品進口國/出口國。 有利的政策框架,完善的醫療體系,不斷增加的醫藥研發支出以及對品牌藥和仿製藥的需求不斷增長是增加該國醫藥市場潛力的主要因素。 德國是拜耳,默克和勃林格殷格翰等幾家大型製藥公司的所在地。 多家製藥公司表示，該國有幾家主要的藥品生產設施，推動了全國各地對藥品生產設備的採用。 法國政府已實施多項措施來簡化監管流程並鼓勵研發。 例如，在2023年，政府將成立一個新的專家委員會，包括法國製藥業,醫療專業人員和患者的代表，以製定預防和管理供應鏈問題的長期方法。我們要打下基礎.

內容

第一章介紹

第二章研究方法論

第 3 章執行摘要

第 4 章重要注意事項

第 5 章市場概述

  • 介紹
  • 市場動態
    • 司機
    • 約束因素
    • 機會
    • 任務
  • 價值鏈分析
  • 生態系統繪圖
  • 價格分析
  • 影響客戶業務的趨勢/顛覆
  • 技術分析
  • 波特的五力分析
  • 主要利益相關者和採購標準
  • 案例研究
  • 貿易分析
  • 專利分析
  • 主要會議和活動 (2022-2023)
  • 法規和標準

第 6 章製藥設備市場：按設備類型分類

  • 介紹
  • 包裝機
  • 灌裝機
  • 噴霧乾燥設備
  • 混合/混合設備
  • 粉碎機
  • 擠出機
  • 壓片機
  • 檢驗設備

第 7 章製藥設備市場：按最終產品類型分類

  • 介紹
  • 固體
  • 液體

第 8 章製藥設備市場：按地區

  • 介紹
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 其他亞太地區
  • 其他地區
    • 中東和非洲
    • 南美洲

第9章競爭格局

  • 概覽
  • 前 5 家公司的收入分析
  • 市場份額分析 (2022)
  • 公司評估象限
  • 中小企業評估象限 (2022)
  • 醫藥包裝機市場：公司足跡
  • 競爭基準
  • 競爭形勢和趨勢

第十章公司簡介

  • 主要公司
    • GEA GROUP AKTIENGESELLSCHAFT
    • I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A
    • SYNTEGON TECHNOLOGY GMBH
    • ACG
    • THERMO FISHER SCIENTIFIC INC.
    • ROMACO GROUP
    • KORBER AG
    • MARCHESINI GROUP
    • MG2 S.R.L
    • GLATT GMBH
  • 其他企業
    • BAKER PERKINS
    • BAUSCH+STROBEL
    • COPERION
    • ELIZABETH COMPANIES
    • FETTE COMPACTING
    • FREUND-VECTOR
    • KORSCH
    • L.B. BOHLE
    • LFA MACHINES
    • CVC TECHNOLOGIES, INC.
    • OHARA TECHNOLOGIES
    • PRISM PHARMA MACHINERY
    • SAINTYCO
    • SILVERSON
    • YENCHEN MACHINERY

第 11 章相鄰和相關市場

第十二章附錄

簡介目錄
Product Code: SE 8645

The pharmaceutical manufacturing equipment market is projected to reach USD 19.7 billion by 2028 from USD 14.5 billion in 2023, at a CAGR of 6.3% from 2023 to 2028. The major factors driving the market growth of the pharmaceutical manufacturing equipment market include increasing number of regulatory frameworks established worldwide to support innovation and safety in drugs, growing demand for generics globally, rising healthcare investment, and growing requirement for flexibility in pharmaceutical manufacturing. Emerging markets for pharmaceutical manufacturing, especially in the Middle East and Africa, is also a key factor driving the demand for technologically advanced pharmaceutical manufacturing equipment.

Packaging machines are expected to register the highest CAGR during the forecast period followed by spray drying equipment

Pharmaceutical packaging machines are critical in the drug manufacturing process as they ensure the quality and safety of medications while meeting regulatory requirements. ackaging machines equipped with serialization capabilities enable unique identification and tracking of individual pharmaceutical products, facilitating supply chain transparency and product authentication, thereby driving their demand. There is a growing emphasis on sustainable packaging practices in the pharmaceutical industry. Packaging machines that support eco-friendly packaging materials, such as recyclable or biodegradable materials, are in demand. Using pharmaceutical spray drying equipment helps ensure that the active pharmaceutical ingredient (API) is evenly distributed throughout the drug formulation and that the final product meets the required specifications for quality, purity, and potency. The efficient and precise spray drying of drug formulations is essential to produce high-quality drug products that are safe and effective for patient use, thereby driving their demand.

Liquid end-product type is expected to register the highest CAGR during the forecast period followed by solid end-product type

Liquid end-product type covers different types of liquid dosage forms including solutions, syrups, suspensions, and emulsions, among others. There is a growing demand for syrups. They offer accurate dosage of drug in a concentrated sugar solution, thus masking the unpleasant taste and therefore being preferred, especially by the geriatric population and children. Technological advancements, extensive research and development activities, and innovation in clinical trials have allowed manufacturers to substantially enhance shelf-life of liquid dosage forms, thereby making them a feasible alternative to many solid dosage forms which have less solubility. Liquid medications have higher bioavailability compared to solid dosage forms, meaning that more of the active ingredient is absorbed into the bloodstream. This can lead to a more effective treatment and a reduced risk of side effects, which is another factor driving their demand.

Asia Pacific is expected to register the highest CAGR during forecast period followed by Europe

Industry players in Asia Pacific are working collaboratively with the government to tackle the shortages of drugs. In addition, high-rate of branded drugs and the expiry of key drug patents are also driving the demand for the adoption of generics. The governments and industry players across the region aim to improve pharmaceutical manufacturing facilities by adopting the latest pharmaceutical manufacturing equipment to serve the growing demand for drugs, eliminate drug shortages, and expand production capacities. India has the highest number of US-FDA-compliant pharma plants outside the US. It is home to over 3,000 pharma companies with a strong network of over 10,500 manufacturing facilities and a highly skilled resource pool. Furthermore, the government of India has implemented schemes, including the Production Linked Incentive (PLI) scheme to boost domestic manufacturing capacity, including high-value products across the global supply chain.

Germany was one of the top importers and exporters of pharmaceutical products in FY 2021. The presence of a favorable policy framework, a well-established healthcare system, increasing pharmaceutical R&D expenditure, and rising demand for branded and generic drugs are the major factors driving the potential of the pharmaceutical market in the country. Germany is home to several major pharmaceutical companies, including Bayer, Merck KGaA, Boehringer Ingelheim, etc. Several pharmaceutical companies indicate the presence of several major pharmaceutical manufacturing facilities in the country, boosting the adoption of pharmaceutical manufacturing equipment across the country. The French government implemented several measures to streamline the regulatory process and promote research and development. For instance, in 2023, the government will form a new dedicated committee, which will include representatives of the French pharma industry, health professionals, and patients to lay the foundations for a longer-term approach to preventing and managing supply chain issues.

The break-up of profile of primary participants in the pharmaceutical manufacturing equipment market-

  • By Company Type: Tier 1 - 40%, Tier 2 - 35%, Tier 3 - 25%
  • By Designation Type: C Level - 48%, Director Level - 33% , Others - 19%
  • By Region Type: North America - 35%, Europe - 18%, Asia Pacific - 40%, Rest of the World - 7%

The major players of pharmaceutical manufacturing equipment market are GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A (Italy), Syntegon Technology GmbH (Germany), ACG (India), and Thermo Fisher Scientific Inc.(US) among others.

Research Coverage

The report segments the pharmaceutical manufacturing equipment market and forecasts its size based on equipment type, end-product type, and region. The report also provides a comprehensive review of drivers, restraints, opportunities, and challenges influencing the market growth. The report also covers qualitative aspects in addition to the quantitative aspects of the market.

Reasons to buy the report:

The report will help the market leaders/new entrants in this market with information on the closest approximate revenues for the overall pharmaceutical manufacturing equipment market and related segments. This report will help stakeholders understand the competitive landscape and gain more insights to strengthen their position in the market and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (globally increasing demand for generics, rising need for flexible pharmaceutical manufacturing, and growing implementation of regulatory frameworks and guidelines), restraints (increasing global demand for refurbished pharmaceutical manufacturing equipment), opportunities (adoption of pharmaceutical manufacturing equipment to enable first-to-market advantages, emerging markets and increasing focus on sustainability, and integration of artificial intelligence (AI) with inspection equipment to provide better quality assurance), and challenges (rising costs and expenditures related to usage of pharmaceutical manufacturing equipment) influencing the growth of the pharmaceutical manufacturing equipment market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the pharmaceutical manufacturing equipment market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the pharmaceutical manufacturing equipment market across varied regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmaceutical manufacturing equipment market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players like GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A (Italy), Syntegon Technology GmbH (Germany), ACG (India), and Thermo Fisher Scientific Inc.(US).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 INCLUSIONS AND EXCLUSIONS
    • TABLE 1 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: INCLUSIONS AND EXCLUSIONS
  • 1.4 STUDY SCOPE
    • 1.4.1 MARKETS COVERED
    • FIGURE 1 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: SEGMENTATION
    • 1.4.2 GEOGRAPHICAL SCOPE
    • FIGURE 2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: GEOGRAPHIC SEGMENTATION
    • 1.4.3 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
  • 1.6 LIMITATIONS
  • 1.7 STAKEHOLDERS
  • 1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 3 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY AND PRIMARY RESEARCH
    • 2.1.2 SECONDARY DATA
      • 2.1.2.1 Major secondary sources
      • 2.1.2.2 Key data from secondary sources
    • 2.1.3 PRIMARY DATA
      • 2.1.3.1 Primary interviews with experts
      • 2.1.3.2 Key data from primary sources
      • 2.1.3.3 Key industry insights
      • 2.1.3.4 Breakdown of primaries
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY (SUPPLY SIDE): REVENUE GENERATED FROM PHARMACEUTICAL PACKAGING MACHINES IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach to arrive at market size through bottom-up analysis (demand side)
    • FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
      • 2.2.2.1 Approach to arrive at market size through top-down analysis (supply side)
    • FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
    • FIGURE 8 ASSUMPTIONS FOR RESEARCH STUDY
  • 2.5 PARAMETERS CONSIDERED TO ANALYZE RECESSION IMPACT
  • 2.6 RESEARCH LIMITATIONS AND RISK ASSESSMENT
    • TABLE 2 LIMITATIONS AND ASSOCIATED RISKS

3 EXECUTIVE SUMMARY

    • FIGURE 9 PACKAGING MACHINES TO HOLD DOMINANT SHARE OF MARKET
    • FIGURE 10 LIQUID END PRODUCT TYPE TO CLAIM LARGEST SHARE IN MARKET
    • FIGURE 11 ASIA PACIFIC HELD LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN 2022

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE GROWTH OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
    • FIGURE 12 RISING DEMAND FOR GENERICS AND GROWING NECESSITY FOR FLEXIBLE PHARMACEUTICAL MANUFACTURING TO PROVIDE OPPORTUNITIES FOR PLAYERS IN MARKET
  • 4.2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE
    • FIGURE 13 PACKAGING MACHINES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • 4.3 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE
    • FIGURE 14 LIQUID SEGMENT TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD
  • 4.4 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY
    • FIGURE 15 US TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 16 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising demand for generics
      • 5.2.1.2 Need for flexible pharmaceutical manufacturing
      • 5.2.1.3 Growing implementation and adoption of regulatory guidelines
    • FIGURE 17 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF DRIVERS
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Demand for refurbished equipment
    • FIGURE 18 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF RESTRAINTS
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Adoption of pharmaceutical manufacturing equipment to enable first-to-market advantages
      • 5.2.3.2 Integration of artificial intelligence with inspection equipment to provide better quality assurance
      • 5.2.3.3 Emerging markets and increased focus on sustainability
    • FIGURE 19 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF OPPORTUNITIES
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Rising costs and expenditures related to usage of pharmaceutical manufacturing equipment
    • FIGURE 20 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF CHALLENGES
  • 5.3 VALUE CHAIN ANALYSIS
    • FIGURE 21 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: VALUE CHAIN ANALYSIS
  • 5.4 ECOSYSTEM MAPPING
    • FIGURE 22 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: ECOSYSTEM ANALYSIS
    • TABLE 3 COMPANIES AND THEIR ROLE IN PHARMACEUTICAL MANUFACTURING EQUIPMENT ECOSYSTEM
  • 5.5 PRICING ANALYSIS
    • 5.5.1 COMPANY-WISE AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT, BY EQUIPMENT TYPE
    • TABLE 4 AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT, BY EQUIPMENT TYPE
    • FIGURE 23 AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT BY KEY PLAYERS, BY EQUIPMENT TYPE (USD)
    • TABLE 5 AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT OFFERED BY THREE GLOBAL PLAYERS, BY EQUIPMENT TYPE
    • TABLE 6 AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING MACHINE, BY REGION
    • FIGURE 24 AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING MACHINE, 2019-2028
  • 5.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
    • FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.7 TECHNOLOGY ANALYSIS
    • 5.7.1 INDUSTRY 4.0
    • 5.7.2 COMPUTER VISION
    • 5.7.3 RADIO FREQUENCY IDENTIFICATION
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 26 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 BARGAINING POWER OF SUPPLIERS
    • 5.8.2 BARGAINING POWER OF BUYERS
    • 5.8.3 THREAT OF NEW ENTRANTS
    • 5.8.4 THREAT OF SUBSTITUTES
    • 5.8.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 27 INFLUENCE OF STAKEHOLDERS IN PHARMACEUTICAL INDUSTRY ON BUYING PROCESS
    • TABLE 7 INFLUENCE OF STAKEHOLDERS IN TOP THREE END-USER INDUSTRIES ON BUYING PROCESS
    • 5.9.2 BUYING CRITERIA
    • FIGURE 28 KEY BUYING CRITERIA FOR PHARMACEUTICAL INDUSTRY
    • TABLE 8 KEY BUYING CRITERIA OF TOP THREE INDUSTRIES
  • 5.10 CASE STUDIES
    • TABLE 9 ALCAMI CORPORATION CHOOSES SYNTEGON TO INCREASE ITS VIAL FILLING FLEXIBILITY
    • TABLE 10 LEADING MANUFACTURER OF GENERIC DRUG PRODUCTS IN RUSSIA CHOOSES GEA GROUP TO EXPAND THEIR REACH AND INTEGRATE ADVANCED MANUFACTURING EQUIPMENT
    • TABLE 11 CDM LAVOISIER ADOPTS SYNTEGON AIM 3000 FOR INSPECTION OF 30 DIFFERENT PRODUCTS ON FOUR PACKAGING FORMATS
  • 5.11 TRADE ANALYSIS
    • FIGURE 29 IMPORT DATA FOR MACHINERY FOR FILLING, CLOSING, SEALING, OR LABELLING BOTTLES, CANS, BOXES, BAGS, OR OTHER CONTAINERS; MACHINERY FOR CAPSULING BOTTLES, JARS, TUBES, AND SIMILAR CONTAINERS; MACHINERY FOR AERATING BEVERAGES, 2017-2021 (USD MILLION)
    • FIGURE 30 EXPORT DATA FOR MACHINERY FOR FILLING, CLOSING, SEALING, OR LABELLING BOTTLES, CANS, BOXES, BAGS, OR OTHER CONTAINERS; MACHINERY FOR CAPSULING BOTTLES, JARS, TUBES, AND SIMILAR CONTAINERS; MACHINERY FOR AERATING BEVERAGES, 2017-2021 (USD MILLION)
  • 5.12 PATENT ANALYSIS
    • 5.12.1 LIST OF MAJOR PATENTS
    • TABLE 12 KEY PATENTS IN AREA OF PHARMACEUTICAL MANUFACTURING EQUIPMENT
  • 5.13 KEY CONFERENCES AND EVENTS, 2022-2023
    • TABLE 13 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: REGION-WISE CONFERENCES AND EVENTS
  • 5.14 REGULATIONS AND STANDARDS
    • 5.14.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 16 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 17 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.14.2 STANDARDS
    • TABLE 18 STANDARDS FOLLOWED BY MANUFACTURERS OF PHARMACEUTICAL MANUFACTURING EQUIPMENT

6 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE

  • 6.1 INTRODUCTION
    • FIGURE 31 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE
    • FIGURE 32 PACKAGING MACHINES TO LEAD MARKET THROUGHOUT FORECAST PERIOD
    • TABLE 19 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 20 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
  • 6.2 PACKAGING MACHINES
    • 6.2.1 RISING NECESSITY FOR ENSURING PROTECTION AGAINST DAMAGE AND CONTAMINATION
    • TABLE 21 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 22 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 23 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 24 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 25 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 26 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 27 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 28 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023-2028 (USD MILLION)
  • 6.3 FILLING MACHINES
    • 6.3.1 GROWING DEMAND FOR ENSURING PRECISION FILLING OF DRUG FORMULATIONS
    • TABLE 29 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 30 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 31 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 32 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 33 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 34 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 35 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 36 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023-2028 (USD MILLION)
  • 6.4 SPRAY DRYING EQUIPMENT
    • 6.4.1 GROWING NECESSITY FOR HIGH-QUALITY DRUGS
    • TABLE 37 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 38 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 39 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 40 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 41 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 42 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 43 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 44 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023-2028 (USD MILLION)
  • 6.5 MIXING AND BLENDING MACHINES
    • 6.5.1 DEMAND TO MAINTAIN UNIFORMITY OF DRUG FORMULATIONS FOR HOMOGENEITY TO DRIVE MARKET
    • TABLE 45 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 46 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 47 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 48 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 49 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 50 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 51 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 52 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023-2028 (USD MILLION)
  • 6.6 MILLING EQUIPMENT
    • 6.6.1 RISING NECESSITY TO IMPROVE SOLUBILITY OF DRUGS
    • TABLE 53 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 54 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 55 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 56 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 57 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 58 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 59 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 60 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023-2028 (USD MILLION)
  • 6.7 EXTRUSION EQUIPMENT
    • 6.7.1 NECESSITY FOR DEVELOPING DRUGS IN EFFECTIVE SHAPES AND MAINTAINING PROPER DRUG FORMULATION
    • TABLE 61 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 62 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 63 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 64 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 65 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 66 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 67 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 68 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023-2028 (USD MILLION)
  • 6.8 TABLET COMPRESSION PRESSES
    • 6.8.1 RISING DEMAND TO PRODUCE LARGE BATCHES OF TABLETS QUICKLY
    • TABLE 69 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 70 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 71 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 72 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 73 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 74 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 75 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 76 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023-2028 (USD MILLION)
  • 6.9 INSPECTION EQUIPMENT
    • 6.9.1 RISING DEMAND TO ADHERE TO QUALITY STANDARDS
    • TABLE 77 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 78 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 79 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 80 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 81 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 82 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 83 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 84 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023-2028 (USD MILLION)

7 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE

  • 7.1 INTRODUCTION
    • FIGURE 33 LIQUID END-PRODUCT TYPE TO HOLD LARGER MARKET SHARE THROUGHOUT FORECAST PERIOD
    • TABLE 85 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2019-2022 (USD MILLION)
    • TABLE 86 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2023-2028 (USD MILLION)
  • 7.2 SOLID
    • 7.2.1 RISING DEMAND FOR TABLETS
  • 7.3 LIQUID
    • 7.3.1 EASE OF ADMINISTRATION AND HIGH SOLUBILITY

8 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION

  • 8.1 INTRODUCTION
    • FIGURE 34 INDIA TO REGISTER HIGHEST CAGR IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD
    • FIGURE 35 ASIA PACIFIC TO ACCOUNT FOR LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD
    • TABLE 87 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 88 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 8.2 NORTH AMERICA
    • FIGURE 36 NORTH AMERICA: SNAPSHOT OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
    • FIGURE 37 US TO REGISTER HIGHEST CAGR IN NORTH AMERICAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD
    • TABLE 89 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 90 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 91 US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 92 US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 93 CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 94 CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 95 MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 96 MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 97 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 98 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • 8.2.1 US
      • 8.2.1.1 Stringent regulatory framework and growing demand for innovative drugs
    • 8.2.2 CANADA
      • 8.2.2.1 Establishment of new drug development facilities and government measures
    • 8.2.3 MEXICO
      • 8.2.3.1 Development of pharmaceutical manufacturing units by global players
  • 8.3 EUROPE
    • FIGURE 38 EUROPE: SNAPSHOT OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
    • FIGURE 39 GERMANY TO REGISTER HIGHEST CAGR IN EUROPEAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD
    • TABLE 99 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 100 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 101 UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 102 UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 103 GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 104 GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 105 FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 106 FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 107 ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 108 ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 109 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 110 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • 8.3.1 UK
      • 8.3.1.1 Strong pharmaceutical manufacturing sector
    • 8.3.2 GERMANY
      • 8.3.2.1 Presence of major pharmaceutical players
    • 8.3.3 FRANCE
      • 8.3.3.1 Growing demand for generics
    • 8.3.4 ITALY
      • 8.3.4.1 Growing government support
    • 8.3.5 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • FIGURE 40 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT
    • FIGURE 41 INDIA TO REGISTER HIGHEST CAGR IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD
    • TABLE 111 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 112 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 113 CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 114 CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 115 JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 116 JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 117 INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 118 INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 119 SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 120 SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 121 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 122 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • 8.4.1 CHINA
      • 8.4.1.1 Growing contract pharmaceutical manufacturing
    • 8.4.2 JAPAN
      • 8.4.2.1 Collaboration of associations and industry players to eliminate drug shortages
    • 8.4.3 INDIA
      • 8.4.3.1 Establishment of new pharmaceutical manufacturing units
    • 8.4.4 SOUTH KOREA
      • 8.4.4.1 Increasing government initiatives to support market growth
    • 8.4.5 REST OF ASIA PACIFIC
  • 8.5 REST OF THE WORLD
    • FIGURE 42 SOUTH AMERICA TO DOMINATE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW DURING FORECAST PERIOD
    • TABLE 123 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 124 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 125 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 126 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • 8.5.1 MIDDLE EAST & AFRICA
      • 8.5.1.1 Growing regulatory environment
    • 8.5.2 SOUTH AMERICA
      • 8.5.2.1 Growing pharmaceutical manufacturing infrastructure

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
    • TABLE 127 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
  • 9.2 REVENUE ANALYSIS OF TOP FIVE PLAYERS
    • FIGURE 43 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: MARKET SHARE ANALYSIS (2022)
  • 9.3 MARKET SHARE ANALYSIS, 2022
    • TABLE 128 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: MARKET SHARE OF KEY COMPANIES
    • FIGURE 44 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: MARKET SHARE ANALYSIS
  • 9.4 COMPANY EVALUATION QUADRANT
    • 9.4.1 STARS
    • 9.4.2 EMERGING LEADERS
    • 9.4.3 PERVASIVE PLAYERS
    • 9.4.4 PARTICIPANTS
    • FIGURE 45 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: COMPANY EVALUATION QUADRANT, 2022
  • 9.5 SMALL- AND MEDIUM-SIZED ENTERPRISES EVALUATION QUADRANT, 2022
    • 9.5.1 PROGRESSIVE COMPANIES
    • 9.5.2 RESPONSIVE COMPANIES
    • 9.5.3 DYNAMIC COMPANIES
    • 9.5.4 STARTING BLOCKS
    • FIGURE 46 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET (GLOBAL): SME EVALUATION QUADRANT, 2022
  • 9.6 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: COMPANY FOOTPRINT
    • TABLE 129 COMPANY FOOTPRINT
    • TABLE 130 PRIMARY PACKAGING EQUIPMENT: COMPANY FOOTPRINT
    • TABLE 131 SECONDARY PACKAGING EQUIPMENT: COMPANY FOOTPRINT
    • TABLE 132 TYPE: COMPANY FOOTPRINT
    • TABLE 133 REGION: COMPANY FOOTPRINT
  • 9.7 COMPETITIVE BENCHMARKING
    • TABLE 134 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUPS/SMES
    • TABLE 135 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • 9.8 COMPETITIVE SITUATIONS AND TRENDS
    • 9.8.1 PRODUCT LAUNCHES
    • TABLE 136 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PRODUCT LAUNCHES, APRIL 2020-JANUARY 2023
    • 9.8.2 DEALS
    • TABLE 137 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DEALS, JANUARY 2021-MARCH 2023

10 COMPANY PROFILES

  • (Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)**
  • 10.1 KEY PLAYERS
    • 10.1.1 GEA GROUP AKTIENGESELLSCHAFT
    • TABLE 138 GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW
    • FIGURE 47 GEA GROUP AKTIENGESELLSCHAFT: COMPANY SNAPSHOT
    • TABLE 139 GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 140 GEA GROUP AKTIENGESELLSCHAFT: PRODUCT LAUNCHES & DEVELOPMENTS
    • TABLE 141 GEA GROUP AKTIENGESELLSCHAFT: DEALS
    • 10.1.2 I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A
    • TABLE 142 I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A : COMPANY OVERVIEW
    • TABLE 143 I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A: PRODUCT/SOLUTIONS/SERVICES OFFERED
    • 10.1.3 SYNTEGON TECHNOLOGY GMBH
    • TABLE 144 SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW
    • TABLE 145 SYNTEGON TECHNOLOGY GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 146 SYNTEGON TECHNOLOGY GMBH: PRODUCT LAUNCHES
    • TABLE 147 SYNTEGON TECHNOLOGY GMBH: DEALS
    • 10.1.4 ACG
    • TABLE 148 ACG: COMPANY OVERVIEW
    • TABLE 149 ACG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 10.1.5 THERMO FISHER SCIENTIFIC INC.
    • TABLE 150 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW
    • FIGURE 48 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
    • TABLE 151 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 152 THERMO FISHER SCIENTIFIC INC.: DEALS
    • 10.1.6 ROMACO GROUP
    • TABLE 153 ROMACO GROUP: COMPANY OVERVIEW
    • TABLE 154 ROMACO GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 155 ROMACO GROUP: PRODUCT LAUNCHES
    • TABLE 156 ROMACO GROUP: DEALS
    • 10.1.7 KORBER AG
    • TABLE 157 KORBER AG: COMPANY OVERVIEW
    • FIGURE 49 KORBER AG: COMPANY SNAPSHOT
    • TABLE 158 KORBER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 159 KORBER AG: DEALS
    • 10.1.8 MARCHESINI GROUP
    • TABLE 160 MARCHESINI GROUP: COMPANY OVERVIEW
    • TABLE 161 MARCHESINI GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 162 MARCHESINI GROUP: PRODUCT LAUNCHES
    • TABLE 163 MARCHESINI GROUP: DEALS
    • 10.1.9 MG2 S.R.L
    • TABLE 164 MG2 S.R.L.: COMPANY OVERVIEW
    • TABLE 165 MG2 S.R.L.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 166 MG2 S.R.L.: PRODUCT LAUNCHES
    • 10.1.10 GLATT GMBH
    • TABLE 167 GLATT GMBH: COMPANY OVERVIEW
    • TABLE 168 GLATT GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • 10.2 OTHER PLAYERS
    • 10.2.1 BAKER PERKINS
    • TABLE 169 BAKER PERKINS: COMPANY OVERVIEW
    • 10.2.2 BAUSCH+STROBEL
    • TABLE 170 BAUSCH+ STROBEL: COMPANY OVERVIEW
    • 10.2.3 COPERION
    • TABLE 171 COPERION: COMPANY OVERVIEW
    • 10.2.4 ELIZABETH COMPANIES
    • TABLE 172 ELIZABETH COMPANIES: COMPANY OVERVIEW
    • 10.2.5 FETTE COMPACTING
    • TABLE 173 FETTE COMPACTING: COMPANY OVERVIEW
    • 10.2.6 FREUND-VECTOR
    • TABLE 174 FREUND-VECTOR: COMPANY OVERVIEW
    • 10.2.7 KORSCH
    • TABLE 175 KORSCH: COMPANY OVERVIEW
    • 10.2.8 L.B. BOHLE
    • TABLE 176 L.B. BOHLE: COMPANY OVERVIEW
    • 10.2.9 LFA MACHINES
    • TABLE 177 LFA MACHINES: COMPANY OVERVIEW
    • 10.2.10 CVC TECHNOLOGIES, INC.
    • TABLE 178 CVC TECHNOLOGIES, INC.: COMPANY OVERVIEW
    • 10.2.11 OHARA TECHNOLOGIES
    • TABLE 179 OHARA TECHNOLOGIES: COMPANY OVERVIEW
    • 10.2.12 PRISM PHARMA MACHINERY
    • TABLE 180 PRISM PHARMA MACHINERY: COMPANY OVERVIEW
    • 10.2.13 SAINTYCO
    • TABLE 181 SAINTYCO: COMPANY OVERVIEW
    • 10.2.14 SILVERSON
    • TABLE 182 SILVERSON: COMPANY OVERVIEW
    • 10.2.15 YENCHEN MACHINERY
    • TABLE 183 YENCHEN MACHINERY: COMPANY OVERVIEW
  • *Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)** might not be captured in case of unlisted companies.

11 ADJACENT AND RELATED MARKETS

  • 11.1 INTRODUCTION
  • 11.2 LIMITATIONS
  • 11.3 SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY SUPPLY CHAIN PARTICIPANT
    • 11.3.1 INTRODUCTION
    • TABLE 184 SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY SUPPLY CHAIN PARTICIPANT, 2019-2022 (USD MILLION)
    • TABLE 185 SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY SUPPLY CHAIN PARTICIPANT, 2023-2028 (USD MILLION)
  • 11.4 IDM FIRMS
    • 11.4.1 FOCUS ON SEMICONDUCTOR DESIGN AND PRODUCTION AND HAVE INTERNAL CAPABILITY TO PERFORM BOTH
    • TABLE 186 IDM FIRMS: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 187 IDM FIRMS: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 11.5 OSAT COMPANIES
    • 11.5.1 LESS INVESTMENTS AND ATTRACTIVE REVENUE FOSTER GROWTH OF OSAT COMPANIES
    • TABLE 188 OSAT COMPANIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 189 OSAT COMPANIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 11.6 FOUNDRIES
    • 11.6.1 INCREASED SEMICONDUCTOR OUTSOURCING BY FABLESS COMPANIES
    • TABLE 190 FOUNDRIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 191 FOUNDRIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 CUSTOMIZATION OPTIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS